How to Value a Dental DSO (Dental Service Organization)

Valuing a single dental practice and valuing a DSO are fundamentally different exercises. I've advised on both, and the gap in complexity is enormous. A solo practice sells on a percentage of collections. A DSO with 12 locations, a management layer, and $4M in EBITDA is a private equity transaction — and it's priced like one.

If you've built a dental platform with five or more locations, you're playing a different game than the dentist down the street selling to an associate. Here's how that game actually works.

What Makes a DSO a DSO

Let me be precise about what we're talking about. A DSO isn't just a dentist who owns three offices. A DSO is a management company that provides non-clinical services — billing, HR, marketing, procurement, compliance, IT — to affiliated dental practices. The clinical operations remain with the licensed dentists. The business operations sit in the DSO.

This distinction matters for valuation because a properly structured DSO has separated the business from any single provider. That's the entire value proposition for PE buyers. When Heartland Dental manages 1,700+ offices or Aspen Dental operates 1,000+ locations, no single dentist leaving tanks the business. That provider independence is what unlocks institutional multiples.

The threshold I see PE firms consistently engage at is five or more locations with at least $2M in consolidated EBITDA. Below that, you're a group practice. Above it, you're a platform candidate.

DSO Multiples: 8-16x EBITDA and Why the Range Is So Wide

The headline multiple range for DSO transactions in 2025-2026 is 8-16x EBITDA. That's a massive spread, and it's not random. Where you land depends on several concrete factors.

Location count and geographic density. A 15-location DSO clustered in two adjacent metro areas is worth more than 15 locations scattered across four states. Geographic clustering enables shared management, centralized procurement, and efficient provider coverage. Pacific Dental Services built its model around dense California clusters before expanding — and that density is part of what drove its valuation north of $10B.

Same-store collections growth.PE buyers obsess over this metric. If your existing locations are growing collections 5-8% annually without acquisitions, you're demonstrating organic demand. If collections are flat and all growth comes from buying new offices, buyers discount heavily because they know the acquisition treadmill eventually stalls.

De novo vs. acquired growth.Opening new locations from scratch (de novo) is harder but signals operational capability. A DSO that has successfully opened 4-5 de novo locations proves it can replicate its model without relying on acquisitions. That's a premium trait. MB2 Dental's growth strategy mixes acquisitions with de novos, and PE sponsors view that blend favorably.

Provider retention rate. If your associate dentists turn over every 18 months, buyers see a staffing problem that will cost millions to manage. Top DSOs retain providers at 85%+ annual rates, often through equity participation, production bonuses, or partnership tracks. Dental Care Alliance historically struggled with provider retention, and it showed up in their valuation discussions.

Management layer depth.This is the one sellers underestimate most. A DSO where the founder-dentist still makes every operational decision is not a platform — it's a group practice with a corporate veneer. PE buyers want a COO, a VP of Operations, regional managers, and a centralized revenue cycle team. If you're the entire C-suite, expect your multiple to sit at 8-10x. If you have a real management team, you're looking at 12-16x.

Platform vs. Add-On Economics

The single most important concept in DSO valuation is the platform vs. add-on distinction, and it creates the biggest arbitrage opportunity in private equity roll-ups.

A platform acquisitionis when a PE firm buys your DSO as the foundation for a dental investment thesis. They're buying your management team, your systems, your brand, and your locations as the base they'll bolt acquisitions onto. Platform deals command 12-16x EBITDA because the PE firm needs you more than you need them — there are only so many well-run DSOs at any given time.

An add-on acquisitionis when an existing PE-backed DSO buys your group to integrate into their platform. You get 5-8x EBITDA because they're providing the management layer, the procurement leverage, and the infrastructure. Your locations are inputs, not the engine.

The arbitrage: a PE firm buys a platform at 12x, bolts on add-ons at 5-7x, and the blended portfolio is worth 14-16x at the next exit because it's bigger, more diversified, and growing faster. That spread between add-on purchase price and portfolio exit multiple is where billions have been made in dental PE.

The Second Bite: Why DSO Founders Get Rich Twice

Here's where DSO economics get genuinely unusual. In most PE transactions, you sell 100% and walk away. In dental, the standard structure is a "first bite / second bite" deal.

The typical structure: you sell 60-70% of your DSO to a PE firm in the first transaction. You retain 30-40% equity and continue running the business. Over the next 3-5 years, the PE firm injects capital to acquire add-on practices, build out infrastructure, and grow the platform 2-3x. Then the PE firm sells the entire platform to the next buyer — a larger PE firm, a strategic acquirer, or takes it public.

Your retained 30-40% equity is now worth more than your original 100% was. I've seen DSO founders where the second bite generated 2-4x what they received in the first transaction. MB2 Dental's partnership with KKR is a textbook example — the founder retained meaningful equity through a recapitalization, and the platform's subsequent growth made that retained stake enormously valuable.

This structure also means that the valuation negotiation isn't purely about the upfront multiple. The rollover equity terms — what class of equity you get, liquidation preferences, anti-dilution protections, board representation — can matter as much as the headline number.

Key Metrics PE Buyers Scrutinize

When a PE firm conducts due diligence on your DSO, they're building a model around these specific data points:

• Collections per location: $800K-$1.5M annually is healthy for a general dentistry location. Below $600K signals underperformance or market saturation.
• EBITDA margin: 18-25% at the consolidated level is the target range. Below 15% suggests operational inefficiency that needs fixing post-close.
• Provider productivity: Collections per provider-day. Top DSOs run $3,500-$5,000 per provider per day. Below $2,500 is a red flag.
• Patient acquisition cost: What you spend on marketing per new patient. DSOs that can acquire patients at $150-250 each have a sustainable engine. Above $400 and the model starts to strain.
• Payor mix: Heavy Medicaid exposure (above 30%) significantly discounts your multiple. Fee-for-service and PPO dominance is what buyers want.
• Lease portfolio: Remaining lease terms across all locations. Short leases without renewal options are a diligence issue that can delay or kill deals.

What Separates a Group Practice from a Real DSO

I see this confusion constantly. A dentist owns seven locations and calls it a DSO. But when I look under the hood, the owner is still treating patients four days a week, there's no centralized billing, each office runs its own P&L with different software, and the "management company" is a QuickBooks file and a part-time office manager.

That's a group practice, and it'll sell at group practice multiples (6-9x EBITDA). To command true DSO multiples, you need:

• Centralized revenue cycle management across all locations
• Standardized clinical protocols and supply chain procurement
• A management team that operates independently of any single provider
• Consistent branding and patient experience across locations
• Scalable technology infrastructure (single PMS, centralized reporting)
• Documented SOPs that a new operator could follow

If you're 18-24 months from a potential exit, investing in this infrastructure now is the highest-ROI move you can make. Going from a group practice multiple to a DSO multiple on $3M EBITDA is the difference between a $24M exit and a $42M exit.

The Competitive Landscape in 2026

The DSO market has matured significantly. Aspen Dental, Heartland Dental, and Pacific Dental Services dominate at the top. Mid-market players like MB2 Dental, Dental Care Alliance, and North American Dental Group compete aggressively for add-on acquisitions. And a wave of newer PE-backed platforms are emerging in specialty verticals — orthodontics, oral surgery, pediatric dentistry.

For DSO founders, this means the buyer universe is deeper than it's ever been. But it also means PE firms are more sophisticated. They've seen enough dental deals to know exactly what works and what doesn't. Sloppy financials, provider turnover problems, or concentration in a single market will get flagged immediately.

The smartest founders I work with start building toward an exit two to three years out. They professionalize their management, tighten their reporting, and grow strategically rather than opportunistically. When the PE process kicks off, there are no surprises — and the multiple reflects that preparation.

The Bottom Line

A single dental practice sells on collections. A DSO sells on EBITDA, growth trajectory, management depth, and PE-readiness. The multiple difference between a well-structured DSO and a loose collection of dental offices under one owner can be 2x on the same underlying earnings. If you've built something with five or more locations and real management infrastructure, you're sitting on a platform-grade asset — price it accordingly.